ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,039 filers reported holding ASTRAZENECA PLC in Q4 2022. The put-call ratio across all filers is 1.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,320,520 | -45.6% | 241,000 | -42.5% | 0.25% | -52.5% |
| Q2 2023 | $29,982,176 | +15.0% | 418,921 | +11.6% | 0.53% | +5.6% |
| Q1 2023 | $26,063,455 | -9.1% | 375,500 | -11.2% | 0.50% | +12.3% |
| Q4 2022 | $28,679,400 | +12.1% | 423,000 | -9.3% | 0.45% | +26.9% |
| Q3 2022 | $25,580,000 | +230.9% | 466,465 | +298.7% | 0.35% | +229.9% |
| Q2 2022 | $7,731,000 | +2235.6% | 117,000 | +2240.0% | 0.11% | +2575.0% |
| Q1 2022 | $331,000 | -99.2% | 5,000 | -99.3% | 0.00% | -99.2% |
| Q4 2021 | $43,578,000 | -30.8% | 748,100 | -28.7% | 0.49% | -32.2% |
| Q3 2021 | $63,010,000 | +56.6% | 1,049,112 | +56.2% | 0.72% | +37.6% |
| Q2 2021 | $40,237,000 | +229.3% | 671,700 | +173.3% | 0.52% | +99.2% |
| Q1 2021 | $12,219,000 | +258.9% | 245,759 | +260.9% | 0.26% | +237.2% |
| Q4 2020 | $3,405,000 | -86.3% | 68,100 | -85.5% | 0.08% | -90.5% |
| Q2 2020 | $24,765,000 | – | 468,250 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |